← All candidates
76 insider filings on record.
76 filings on record.
CPRXCATALYST PHARMACEUTICALS, INC.
—
$31.47
+0.00% · Jul 9
76 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 11 sells
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
71 more transactions on Pro →Context
Wall St
$31.67 avg target
+0.6% vs today · 3 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.79 act+$0.15
Q4 '25$0.68 act+$0.18
Q3 '25$0.68 act+$0.14
Q2 '25$0.68 act+$0.14
Coverage
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I DataZacks · 07-02Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?Zacks · 06-10Angelini Buyout And FIRDAPSE Settlement Reframe Catalyst Pharmaceuticals StorySimply Wall St. · 05-20CPRX or UTHR: Which Is the Better Value Stock Right Now?Zacks · 05-14
The file stays open
76 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice